HomeDMN • FRA
add
Diamyd Medical AB
Nakaraang pagsara
€1.45
Sakop ng araw
€1.46 - €1.46
Sakop ng taon
€0.65 - €1.78
Market cap
1.76B SEK
Average na Volume
2.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Nob 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 25.00K | -26.47% |
Gastos sa pagpapatakbo | 41.86M | 40.27% |
Net na kita | -36.16M | -10.31% |
Net profit margin | -144.65K | -50.02% |
Kita sa bawat share | — | — |
EBITDA | -41.40M | -39.63% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Nob 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 152.88M | -13.49% |
Kabuuang asset | 222.89M | -15.45% |
Kabuuang sagutin | 66.78M | 25.66% |
Kabuuang equity | 156.11M | — |
Natitirang share | 104.09M | — |
Presyo para makapag-book | 0.97 | — |
Return on assets | -48.78% | — |
Return on capital | -71.05% | — |
Cash Flow
Net change in cash
| (SEK) | Nob 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -36.16M | -10.31% |
Cash mula sa mga operasyon | -41.82M | -50.37% |
Cash mula sa pag-invest | 24.06M | 820.26% |
Cash mula sa financing | 59.07M | -27.87% |
Net change in cash | 40.12M | -18.43% |
Malayang cash flow | -31.11M | -43.94% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
29
